E. Majerus

发表

Multi‐step binding of ADAMTS‐13 to von Willebrand factor

J. Sadler, K. Vanhoorelbeke, H. Feys, 2009, Journal of thrombosis and haemostasis : JTH.

ADAMTS13 Bound to Endothelial Cells Exhibits Enhanced Cleavage of von Willebrand Factor*

E. Majerus, Anthony N. Vomund, Elaine M. Majerus, 2009, The Journal of Biological Chemistry.

Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease

J. Sadler, E. Tuley, P. Anderson, 2006, Proceedings of the National Academy of Sciences.

Binding of ADAMTS13 to von Willebrand Factor*

J. Sadler, P. Anderson, E. Majerus, 2005, Journal of Biological Chemistry.

Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson.

D. Neuberg, O. Onyekwere, J. Keefer, 2013, Blood.

A Phase I Single Ascending Dose Study Of NKTT120 In Stable Adult Sickle Cell Patients

R. Mashal, K. Ataga, C. Eaton, 2013 .

Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease.

D. Neuberg, V. Gordeuk, J. Linden, 2017, Blood advances.

Peters Plus Syndrome Mutations Disrupt a Noncanonical ER Quality-Control Mechanism

Deepika Vasudevan, H. Takeuchi, R. Haltiwanger, 2015, Current Biology.

Cleavage of von Willebrand Factor Requires the Spacer Domain of the Metalloprotease ADAMTS13*

J. Sadler, Xinglong Zheng, K. Nishio, 2003, Journal of Biological Chemistry.

O-Fucosylation Is Required for ADAMTS13 Secretion*♦

R. Haltiwanger, K. B. Luther, M. Dlugosz, 2007, Journal of Biological Chemistry.

NNKTT120, an anti-iNKT cell monoclonal antibody, produces rapid and sustained iNKT cell depletion in adults with sickle cell disease

R. Mashal, K. Ataga, E. Vichinsky, 2017, PloS one.

Factor XI/ADAMTS13 complexes are quantitatively insignificant in human plasma.

J. Sadler, K. Vanhoorelbeke, H. Feys, 2007, Haematologica.

ADAMTS13 and TTP

J. Sadler, Xinglong Zheng, E. Majerus, 2002, Current opinion in hematology.

NKTT120 Reduces iNKT Cells without Dose Limiting Toxicity in Stable Adult Sickle Cell Patients in a Phase 1 Trial

K. Ataga, E. Vichinsky, C. Eaton, 2014 .

Sickle cell disease (SCD), iNKT cells, and regadenoson infusion.

D. Neuberg, O. Onyekwere, J. Keefer, 2012, Transactions of the American Clinical and Climatological Association.

Structure of von Willebrand Factor-cleaving Protease (ADAMTS13), a Metalloprotease Involved in Thrombotic Thrombocytopenic Purpura*

K. Fujikawa, J. Sadler, T. Takayama, 2001, The Journal of Biological Chemistry.

Cleavage of the ADAMTS13 Propeptide Is Not Required for Protease Activity*

J. Sadler, Xinglong Zheng, E. Tuley, 2003, Journal of Biological Chemistry.

Valoctocogene roxaparvovec gene transfer in participants with HIV

S. Fong, M. Ragni, E. Majerus, 2023, Blood advances.